Atea Pharmaceuticals, Inc. Quarterly Assets in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Atea Pharmaceuticals, Inc. quarterly Assets history and growth rate from Q4 2019 to Q3 2024.
Atea Pharmaceuticals, Inc. Assets for the quarter ending September 30, 2024 was $491M, a 19.3% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$491M	-$117M	-19.3%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$510M	-$116M	-18.5%	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$553M	-$85.1M	-13.3%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$595M	-$71.7M	-10.8%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$608M	-$78.5M	-11.4%	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$626M	-$68.3M	-9.84%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$638M	-$79.1M	-11%	Mar 31, 2023	10-Q	2023-05-08
Q4 2022	$667M	-$106M	-13.7%	Dec 31, 2022	10-K	2024-02-28
Q3 2022	$687M	-$157M	-18.6%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$694M	-$177M	-20.3%	Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$717M	-$123M	-14.7%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$773M	-$90.7M	-10.5%	Dec 31, 2021	10-K	2023-02-28
Q3 2021	$844M	+$733M	+666%	Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$872M			Jun 30, 2021	10-Q	2021-08-12
Q1 2021	$841M			Mar 31, 2021	10-Q	2021-05-13
Q4 2020	$864M	+$842M	+3813%	Dec 31, 2020	10-K	2022-02-28
Q3 2020	$110M			Sep 30, 2020	10-Q	2020-12-10
Q4 2019	$22.1M			Dec 31, 2019	10-K	2021-03-30

* An asterisk sign (*) next to the value indicates that the value is likely invalid.